| Erlotinib in lung cancer—molecular and clinical predictors of outcome MS Tsao, A Sakurada, JC Cutz, CQ Zhu, S Kamel-Reid, J Squire, ... New England Journal of Medicine 353 (2), 133-144, 2005 | 2307 | 2005 |
| Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 CQ Zhu, G da Cunha Santos, K Ding, A Sakurada, JC Cutz, N Liu, ... Journal of clinical oncology 26 (26), 4268-4275, 2008 | 874 | 2008 |
| Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK Y Storozhuk, SN Hopmans, T Sanli, C Barron, E Tsiani, JC Cutz, G Pond, ... British journal of cancer 108 (10), 2021-2032, 2013 | 322 | 2013 |
| Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells T Sanli, A Rashid, C Liu, S Harding, RG Bristow, JC Cutz, G Singh, ... International Journal of Radiation Oncology* Biology* Physics 78 (1), 221-229, 2010 | 253 | 2010 |
| Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias M Yoshimoto, JC Cutz, PAS Nuin, AM Joshua, J Bayani, AJ Evans, ... Cancer genetics and cytogenetics 169 (2), 128-137, 2006 | 218 | 2006 |
| Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study MC Tammemagi, H Schmidt, S Martel, A McWilliams, JR Goffin, ... The lancet oncology 18 (11), 1523-1531, 2017 | 215 | 2017 |
| Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148 AM Oza, EA Eisenhauer, L Elit, JC Cutz, A Sakurada, MS Tsao, ... Journal of Clinical Oncology 26 (26), 4319-4325, 2008 | 158 | 2008 |
| Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells AP Rybak, L He, A Kapoor, JC Cutz, D Tang Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1813 (5), 683-694, 2011 | 146 | 2011 |
| Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential … JC Cutz, J Guan, J Bayani, M Yoshimoto, H Xue, M Sutcliffe, J English, ... Clinical cancer research 12 (13), 4043-4054, 2006 | 140 | 2006 |
| An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line Y Wang, H Xue, JC Cutz, J Bayani, NR Mawji, WG Chen, LJ Goetz, ... Laboratory investigation 85 (11), 1392-1404, 2005 | 139 | 2005 |
| Sulfasalazine‐induced cystine starvation: Potential use for prostate cancer therapy DW Doxsee, PW Gout, T Kurita, M Lo, AR Buckley, Y Wang, H Xue, ... The Prostate 67 (2), 162-171, 2007 | 136 | 2007 |
| Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer CQ Zhu, JC Cutz, N Liu, D Lau, FA Shepherd, JA Squire, MS Tsao British journal of cancer 94 (10), 1452-1459, 2006 | 129 | 2006 |
| Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer S Djalalov, J Beca, JS Hoch, M Krahn, MS Tsao, JC Cutz, NB Leighl Journal of Clinical Oncology 32 (10), 1012-1019, 2014 | 104 | 2014 |
| Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer JC Cutz, KJ Craddock, E Torlakovic, G Brandao, RF Carter, G Bigras, ... Journal of Thoracic Oncology 9 (9), 1255-1263, 2014 | 87 | 2014 |
| α-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells L He, C Fan, A Kapoor, AJ Ingram, AP Rybak, RC Austin, J Dickhout, ... Nature communications 2 (1), 307, 2011 | 86 | 2011 |
| IQGAP2, A candidate tumour suppressor of prostate tumorigenesis Y Xie, J Yan, JC Cutz, AP Rybak, L He, F Wei, A Kapoor, VA Schmidt, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1822 (6), 875-884, 2012 | 75 | 2012 |
| Bmi1 promotes prostate tumorigenesis via inhibiting p16INK4A and p14ARF expression C Fan, L He, A Kapoor, A Gillis, AP Rybak, JC Cutz, D Tang Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1782 (11 …, 2008 | 74 | 2008 |
| Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis J Yan, J De Melo, JC Cutz, T Aziz, D Tang British journal of cancer 110 (10), 2593-2603, 2014 | 71 | 2014 |
| PTEN inhibits BMI1 function independently of its phosphatase activity C Fan, L He, A Kapoor, AP Rybak, J De Melo, JC Cutz, D Tang Molecular cancer 8, 1-14, 2009 | 70 | 2009 |
| Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: Identification of apoptotic genes as targets for … K Al-Romaih, GR Somers, J Bayani, S Hughes, M Prasad, JC Cutz, H Xue, ... Cancer cell international 7, 1-16, 2007 | 62 | 2007 |
